Pfizer and BioNTech have begun enrollment for a clinical trial to test the safety and immune response of their ...

Pfizer and BioNTech are launching a clinical trial to evaluate the safety and efficacy of a vaccine that targets the Covid ...

The drugmakers said the study will evaluate the safety and immune response of the new inoculation in up to 1,420 healthy ...

Pfizer and BioNTech on Tuesday announced the initiation of a clinical trial of an Omicron-targeted vaccine. The study will ...

Pfizer and BioNTech announced on Tuesday that the companies will start a human trial to evaluate the efficacy, safety, and ...

Pfizer and BioNTech are starting clinical trials for an omicron-specific COVID-19 vaccine for adults ages 18-55, the ...

Pfizer and BioNTech will conduct three simultaneous trials in adults to determine if an omicron-specific vaccine is more effective than current shots.

Pfizer CEO Albert Bourla said an omicron vaccine will be ready ... J&J expects more than $3 billion in Covid vaccine sales this year Pfizer and BioNTech launch clinical trial of Covid vaccine ...

Bourla said Pfizer and partner BioNTech SE are working on both an Omicron-targeted vaccine version as well ... Moderna Inc CEO Stephane Bancel said last week that people could need another shot ...

In this article Pfizer CEO Albert Bourla on Monday ... vaccine sales this year Pfizer and BioNTech launch clinical trial of Covid vaccine targeting omicron Two-doses of Pfizer's or Moderna's ...